Introduction

47
Human schistosomiasis is a water-borne debilitating disease caused by a trematode 48 of the genus Schistosoma. It is estimated that 240 million people worldwide are infected 49
with Schistosoma spp. which causes the loss of 1.5 million DALYs (Disability Adjusted 50
Life Years) per year (1). In 1994, the WHO (World Health Organization) together with 51 the Schistosoma Genome Network started a project aimed to sequencing the S. mansoni 52 genome, which was published in 2009 (2) alongside the Schistosoma japonicum 53 genome (3). Three years later the genome of S. haematobium was described (4). 54
Schistosomes' genome size is relatively large 409.5 Mbp for S. mansoni, 376 Mbp for 55 S. haematobium and 403 Mbp for S. japonicum due to the presence of a large number of 56 repetitive sequences (40-45%). 57
In recent years, high-throughput (next generation) sequencing technologies have 58
provided a large amount of data on covering different aspects of schistosome biology. 59
For example, genome sequencing of multiple isolates has revealed the complex 60 population biology of schistosomes (5-6), and RNA-seq transcriptomic studies have 61 allowed a better understanding of the gene expression patterns during these parasites' 62 life cycle (7-12). These data are made available to the research community via databases 63 such as GeneDB, SchistoDB and WormbaseParasite (13) (14) (15) . 64
The most interesting schistosome proteins are those related to host-parasite 65 interactions (16), since they are accessible to the effector mechanisms of the host's 66 9 synthetic peptides were re-suspended in phosphate buffered solution (PBS) and 188 concentrations were determined with a BCA kit of Pierce (Rockford, IL). Peptide 189 toxicity was determined in J774.2 mouse peritoneal macrophage cell line cultures. Cell shaved and wetted with sterile water and then exposed to cercariae for 45 minutes using 214 a ring (55). All mice were euthanized with a lethal dose of 60 mg/kg of pentobarbital 215 plus 2 IU/mL of heparin and then perfused aseptically with PBS and heparin 216 (500 IU/L). Paired worms as well as single males or females were obtained from the 217 portal and mesenteric veins by portal perfusion at 8 weeks post-challenge. The liver and 218 small intestine were digested in 5% KOH (w/v) overnight at 37ºC with shaking and 219 eggs per gram were counted three times using a McMaster chamber by two different 220 researchers. The spleen, gut and liver weights were recorded. Liver injury was assessed 221 by the number of granulomas in the surface determined by two pathologist 222 independently using three micrographs (Olympus SZX9) and ImageJ 1. 45 
Results
254
While the initial identification of kunitz domain containing proteins in S. mansoni 255 was performed using the former v5.0 of the S. mansoni genome assembly (7), an 256 updated and improved version the assembly was released during the production of this 257 manuscript. Gene accession numbers have change between these two versions. The 258 original accession numbers (found in v5.0) used to access nucleotide and amino acid 259 sequences in different steps described in the methods of this manuscript were 260 maintained as much as possible to allow cross-referencing with existing literature. The Smp_147730 (Syn. Smp_311670) sequence was compared to other putative 288 kunitz proteins of Platyhelminthes identified in sequence databases. There were seven 289 sequences retrieved from GeneDB of S. japonicum but only four had a six-cysteine 290 kunitz domain with an identity ranging between 26.05 and 42.03% (Fig. 1A) . Two out 291 of eight S. haematobium sequences present in SchistoDB did not include a kunitz 292 domain and the identity of the remaining proteins to Smp_147730 (Syn. Smp_311670) 293 ranged between 18.05 and 74.62% (Fig. 1B) . Seven kunitz protein sequences in 294
GeneBank were attributed to E. granulosus but only five have a kunitz domain and 295 identities ranged 15.45 to 37.33% (Fig. 1C ). There were six sequences sharing the 296 domain available in GeneBank from E. multilocularis with identities from 14.41 to 297
35.80% out a total of eight retrieved (Fig. 1D) . Three identical F. hepatica sequences 298 were identified in WormBase ParaSite each presenting a kunitz domain and sharing 299 32.93% residue identity with Smp_147730 (Fig. 1E) . 300 301 Transcriptome analysis and differential expression of Smp_147730 (Syn. 302
Smp_311670) kunitz gene 303
Smp_311670 is located in Chromosome 2 (37,805,700 and 37,811,500, forward 304 strand) of the WBPS12 S.mansoni genome assembly. Transcriptome analysis by RNA-305 seq showed that Smp_311670.2 was significantly up-regulated (adjusted p-value < 0.01) 306 in 24 hours schistosomula and adult worms with respect to cercariae. (Fig. 2,  307 Supplementary Table 1. No significant difference was found between cercariae and 3-308 hours-schistosomula (Supplementary Table1). 309
Primers were designed to amplify Smp_147730 DNA (Syn. Smp_311670) sequence 310 using S. mansoni adult DNA, Forw. 5'-TACTGACAGGGCTCACTACGCT-3' and 311
Rev. 5'-ACGCTCGCCTTCACACCCC-3' by TD-PCR, the amplified region spanned 312 exon 1 and 2. A 1444 bp insert was obtained and purified by agarose gel 313 electrophoresis, quantified and sequenced (Fig. 3A) . A consensus sequence was 314 obtained using Bioedit software and compared through BLAST to sequences recorded 315 in databases. 316 317
T-and B-cell epitope prediction and toxicity assessment 318
The online servers SYFPEITHI (http://www.syfpeithi.de (47) collected by perfusion (91%; P = 0.0002) (Table 1) . Also, significant reduction in 339 number of eggs present in the liver (77%; P = 0.0044) and in the small intestine (57%; 340 P = 0.0208) were detected (Table 1) . Liver damage evaluated by the numbers of 341 granulomas on the hepatic surface was also significantly reduced (65%; P = 0.0041) 342 compared with controls ( Figure 4) . BALB/c mice immunized with the SmKB B-cell 343 peptide, also showed a high reduction in female worms (89%; P = 0.0003) (Table 1) , 344 pronounced decreases in the number of eggs present in the liver (81%; P = 0.0030) and 345 in the intestine (77%; P = 0.0028) (Table 1) Moreover, the recombinant SmKI-1 delayed blood clot formation, inhibited several 398 trypsin proteases but had no effect on pancreatic elastase or cathepsins (27). Therefore 399 kunitz proteins are desirable new targets for vaccine development against schistosomes. 400
Recombinant rSmKI-1 has previously been tested as a vaccine candidate as well as 401 fragments involving the kunitz domain and the C-terminal tail (28, 62). 402
The potential of kunitz domain containing proteins as vaccines led us to study the 403 published sequences of these genes in the three main schistosome species (63 identity of the sequence with S. haematobium was the highest, up to 74% but in the 410 other parasites was much lower, up 43%. This indicates that although the structure of 411 kunitz domain was preserved in the different species these proteins could evolve 412 separately and could be species-specific. These sequence differences correspond with 413 the wide functional diversity of kunitz proteins in several species (64). 414
We focused on Smp_147730 (Syn. Smp_311670), studying its expression by RNA-415 seq and its identification by PCR in the S. mansoni strain maintained in our laboratory. 416
We observed high expression of Smp_147730 (Syn. Smp_311670) after the 417 transformation from cercaria to schistosomulum and even higher expression in the adult 418 stage suggesting a role in schisosomulum development and the prolonged exposure in 419 portal mesenteric veins of adults. The skin-or lung-migrating schistosomula and adult 420 stages are regarded as major targets to design vaccines against schistosomes (65). With 421 this in mind, our strategy was to design new synthetic high affinity peptide candidates 422 composed of a short chain of amino acids containing the specific antigen determinant 423 against functional regions that the parasite needs to survive (66). Several epitopes 424 included in a vaccine would trigger humoral and cellular protective response using an 425 adequate adjuvant or delivery system (67). We designed a T-cell peptide of 15 amino 426 acids (SmKT), candidate from Smp_147730 sequence (Syn. Smp_311670), able to 427 stimulate mouse and human MHC class II and a linear B-cell peptide of 20 amino acids 428 (SmKB) based in physicochemical properties able to produce a humoral response. 429
These in silico analyses are considered feasible, fast, and accurate in designing subunit 430 vaccines against infectious diseases and could produce safer vaccines that are easier to 431 manufacture and store than conventional ones (68). We formulated these two candidate 432 peptides in the Adjuvant Adaptation (ADAD) vaccination system because adjuvants are 433 recognized to have crucial importance in vaccine development. This adjuvant approach 434 is a long-term delivery system feasible to use in vaccine development against helminths 435 overcoming the issues of the experimental Freund's adjuvant (54-55). 
